MICROBOT MEDICAL INC. Diluted Shares Outstanding (Weighted Average)
MICROBOT MEDICAL INC. (MBOT) reported Diluted Shares Outstanding (Weighted Average) of 67.16 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 67.16M shares, a 84.07% increase year-over-year.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 67.16M shares, a 116.04% increase year-over-year.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 67.31M shares, a 291.55% increase year-over-year.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 48.10M shares, a 191.99% increase year-over-year.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 45.79M shares, a 192.69% increase from fiscal 2024.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 15.64M shares, a 53.38% increase from fiscal 2023.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 10.20M shares, a 40.49% increase from fiscal 2022.
- MICROBOT MEDICAL INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 7.26M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 67.16M shares 10-Q · filed 2026-08-11 | 67.16M shares 10-Q · filed 2026-08-11 | 67.21M shares derived: average of 3 quarters · filed 2026-08-11 | 62.43M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 67.16M shares 10-Q · filed 2026-05-13 | 67.23M shares derived: average of 2 quarters · filed 2026-05-13 | 60.85M shares derived: average of 3 quarters · filed 2026-05-13 | 54.76M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 67.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 57.70M shares derived: average of 2 quarters · filed 2026-03-26 | 50.63M shares derived: average of 3 quarters · filed 2026-08-11 | 45.79M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 48.10M shares 10-Q · filed 2025-11-12 | 42.29M shares derived: average of 2 quarters · filed 2026-08-11 | 38.62M shares 10-Q · filed 2025-11-12 | 33.21M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 36.49M shares 10-Q · filed 2026-08-11 | 33.80M shares 10-Q · filed 2026-08-11 | 28.25M shares derived: average of 3 quarters · filed 2026-08-11 | 25.31M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 31.09M shares 10-Q · filed 2026-05-13 | 24.14M shares derived: average of 2 quarters · filed 2026-05-13 | 21.58M shares derived: average of 3 quarters · filed 2026-05-13 | 19.90M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 17.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 16.83M shares derived: average of 2 quarters · filed 2026-03-26 | 16.17M shares derived: average of 3 quarters · filed 2026-03-26 | 15.64M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 16.47M shares 10-Q · filed 2025-11-12 | 15.66M shares derived: average of 2 quarters · filed 2025-11-12 | 15.13M shares 10-Q · filed 2025-11-12 | 14.30M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 14.85M shares 10-Q · filed 2025-08-12 | 14.45M shares 10-Q · filed 2025-08-12 | 13.58M shares derived: average of 3 quarters · filed 2025-08-12 | 13.11M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 14.06M shares 10-Q · filed 2025-05-14 | 12.95M shares derived: average of 2 quarters · filed 2025-05-14 | 12.53M shares derived: average of 3 quarters · filed 2025-05-14 | 11.70M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 11.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 11.77M shares derived: average of 2 quarters · filed 2025-03-25 | 10.92M shares derived: average of 3 quarters · filed 2025-03-25 | 10.20M shares 10-K · filed 2025-03-25 |
| 2023-09-30 | 11.71M shares 10-Q · filed 2024-11-13 | 10.45M shares derived: average of 2 quarters · filed 2024-11-13 | 9.65M shares 10-Q · filed 2024-11-13 | 9.16M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 9.20M shares 10-Q · filed 2024-08-14 | 8.61M shares 10-Q · filed 2024-08-14 | 8.31M shares derived: average of 3 quarters · filed 2024-08-14 | 8.01M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 8.01M shares 10-Q · filed 2024-05-15 | 7.87M shares derived: average of 2 quarters · filed 2024-05-15 | 7.61M shares derived: average of 3 quarters · filed 2024-05-15 | 7.49M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | 7.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 7.41M shares derived: average of 2 quarters · filed 2024-03-27 | 7.31M shares derived: average of 3 quarters · filed 2024-03-27 | 7.26M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 7.11M shares 10-Q · filed 2023-11-14 | 7.11M shares derived: average of 2 quarters · filed 2023-11-14 | 7.11M shares 10-Q · filed 2023-11-14 | |
| 2022-06-30 | 7.11M shares 10-Q · filed 2023-08-14 | 7.11M shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |